Brief: Neximmune Reports Third Quarter 2021 Financial Results And Provides Business Updates
Nov 12 (Reuters) - Neximmune Inc NEXI.O :
* NEXIMMUNE REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATES
* Q3 GAAP LOSS PER SHARE $0.65
* EXPECTS EXISTING CASH, CASH EQUIVALENTS AND MARKETABLE
FUND
OPERATING AND CAPITAL EXPENDITURE REQUIREMENTS THROUGH 4Q22
Source text for Eikon: ID:nGNX216Q3D
Further company coverage: NEXI.O
Recent news on Neximmune
See all newsBrief: Neximmune Appointed Albert Marchio As Interim CFO
Brief: NexImmune and Agents Agreed To Terminate Sales Agreement & ATM Program dated June 2022
Brief: NexImmune Says Co Expects Existing Cash And Cash Equivalents Will Be Sufficient To Meet Its Anticipated Cash Requirements Through Mid-February 2024
Brief: Neximmune Gets Notice From Listing Qualifications Department Of Nasdaq
Brief: NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting